Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenling Baizhu Granules for Prevention of Low-risk Colorectal Adenoma Recurrence
NCT06930157Phase 4Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Nov 2025
- Primary completion
- Dec 2028
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Shenling Baizhu Powder in Colorectal Adenoma (CRA), sponsored by Shanghai Jiao Tong University School of Medicine. Started Nov 2025; status: recruiting.
02
Drugs
Shenling Baizhu Powder
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT06930157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06930157.